PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Evaluated the effect of Malva sylvestris mouthwash (15 ml three times daily for 14 days) compared to chlorhexidine mouthwash [PMID:41184820]
Aqueous fractions demonstrated antiviral activity in epithelial and blood cell lines, reducing infectivity by more than 60% in TZM-bl cells [PMID:31429300]
Flower extract (MFE) reduced tumour cell growth without causing significant cytotoxicity or apoptosis [PMID:41683317]
Assessed radioprotective effects against ionizing radiation damages to the liver, kidney, and duodenum [PMID:36969320]
Aqueous extract has been shown to have an anti-ulcerogenic effect [PMID:37855358]
Evidence summary
PubMed sources
- 1.PMID: 37855358 (2024) — Phytochemistry and Pharmacological Activity of Malva sylvestris L: A Detailed Insight. · Combinatorial chemistry & high throughput screening
- 2.PMID: 35471489 (2022) — Complete genome sequence of malva-associated soymovirus 1: a novel virus infecting common mallow. · Virus genes
- 3.PMID: 36418467 (2023) — The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: a review. · Naunyn-Schmiedeberg's archives of pharmacology
- 4.PMID: 31429300 (2021) — Malva sylvestris derivatives as inhibitors of HIV-1 BaL infection. · Natural product research
- 5.PMID: 41184820 (2025) — The effect of Malva sylvestris mouthwash on chemotherapy-induced stomatitis and associated pain in patients with cancer: a triple-blind randomized clinical trial.